Author

Si‐Yang Li

Johns Hopkins University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Eric L. NuermbergeriD· 2 shared Andrew Jesse GarciaiD· 1 shared Anushka AgrawaliD· 1 shared Arghadip DeyiD· 1 shared Brett H. PogostiniD· 1 shared Chaoyang Tang· 1 shared Christopher L. Pennington· 1 shared Deepak V. AlmeidaiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Eric L. NuermbergerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Enhanced dynamic covalent chemistry for the controlled release of small molecules and biologics from a nanofibrous peptide hydrogel platform

Brett H. Pogostin, Samuel X. Wu, Michael J. Swierczynski, Christopher L. Pennington, Si‐Yang Li, Dilrasbonu Vohidova, Erin H. Seeley, Anushka Agrawal, Chaoyang Tang, Marina H. Yu, Arghadip Dey, Sofia Hernandez, Jacob Cabler, Omid Veiseh A, Eric L. Nuermberger, , Kevin J. McHugh

This study develops SABER hydrogels that extend drug release and therapeutic effect for small molecules and biologics in preclinical models.

Nature Nanotechnology · Sep 10, 2025Peer-reviewedBioengineering

Contribution of telacebec to novel drug regimens in a murine tuberculosis model

Oliver D. Komm, Sandeep K. Tyagi, Andrew Jesse Garcia, Deepak V. Almeida, Yong Seok Chang, Si‐Yang Li, Jennie Ruelas Castillo, Paul J. Converse, Todd A. Black, Nader Fotouhi, Eric L. Nuermberger

This study evaluates telacebec's contribution to combination therapies against two M. tuberculosis strains in a murine model, finding synergistic effects against HN878 and antagonistic effects against H37Rv.

Antimicrobial Agents and Chemotherapy · Dec 9, 2024Peer-reviewedMicrobiology